These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12412390

  • 1. Allogeneic bone marrow transplantation versus chemotherapy in childhood very high risk acute lymphoblastic leukemia in first complete remission: a controversial issue.
    Uderzo C, Balduzzi A.
    Haematologica; 2002 Aug; 87(8 Suppl):47-50. PubMed ID: 12412390
    [Abstract] [Full Text] [Related]

  • 2. Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission.
    Uderzo C.
    Haematologica; 2000 Nov; 85(11 Suppl):9-11. PubMed ID: 11268333
    [Abstract] [Full Text] [Related]

  • 3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 4. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
    Balduzzi A, De Lorenzo P, Schrauder A, Conter V, Uderzo C, Peters C, Klingebiel T, Stary J, Felice MS, Magyarosy E, Schrappe M, Dini G, Gadner H, Valsecchi MG.
    Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
    [Abstract] [Full Text] [Related]

  • 5. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B, Peters C, Ebell W, Zimmermann M, Niggli F, Ludwig WD, Riehm H, Welte K, Schrappe M.
    J Clin Oncol; 2006 Dec 20; 24(36):5742-9. PubMed ID: 17179108
    [Abstract] [Full Text] [Related]

  • 6. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 20; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J.
    Pediatr Blood Cancer; 2005 Aug 20; 45(2):111-20. PubMed ID: 15782402
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain.
    Haematologica; 2005 Oct 20; 90(10):1346-56. PubMed ID: 16219571
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
    Saarinen UM, Mellander L, Nysom K, Ringden O, Schroeder H, Glomstein A, Gustafsson G.
    Bone Marrow Transplant; 1996 Mar 20; 17(3):357-63. PubMed ID: 8704687
    [Abstract] [Full Text] [Related]

  • 11. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
    Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G.
    J Clin Oncol; 2007 Jan 01; 25(1):16-24. PubMed ID: 17194902
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on).
    Torres A, Alvarez MA, Sánchez J, Flores R, Martinez F, Gómez P, Rojas R, Herrera C, García JM, Andrés P, Velasco F, Serrano J, Román J, Rodriguez A, Martin C, Tabares S, Rodriguez JM, Parody R, Plaza E, León A, Romero R, Jean-Paul E, Prados D, Aljama R, Fernández A.
    Bone Marrow Transplant; 1999 Jun 01; 23(12):1257-60. PubMed ID: 10414912
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 01; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 14. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.
    J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318
    [Abstract] [Full Text] [Related]

  • 16. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison.
    Gupta V, Yi QL, Brandwein J, Minden MD, Schuh AC, Wells RA, Chun K, Kamel-Reid S, Tsang R, Daly A, Kiss T, Lipton JH, Messner HA.
    Bone Marrow Transplant; 2004 Feb 15; 33(4):397-404. PubMed ID: 14688816
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC.
    Biol Blood Marrow Transplant; 2007 Sep 15; 13(9):1083-94. PubMed ID: 17697971
    [Abstract] [Full Text] [Related]

  • 18. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML, Langston A, Winton E, Flowers CR, Waller EK.
    Biol Blood Marrow Transplant; 2007 Jan 15; 13(1):116-23. PubMed ID: 17222760
    [Abstract] [Full Text] [Related]

  • 19. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?
    Willemze R, Labar B.
    Semin Hematol; 2007 Oct 15; 44(4):267-73. PubMed ID: 17961726
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME.
    J Clin Oncol; 2006 Jul 01; 24(19):3150-6. PubMed ID: 16717292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.